Background: There is limited data on cerebrospinal fluid (CSF) biomarkers in sporadic
amyloid-ß (Aß) cerebral amyloid angiopathy (CAA). Objective: To determine the profile of
biomarkers relevant to neurodegenerative disease in the CSF of patients with CAA.
Methods: We performed a detailed comparison of CSF markers, comparing patients with
CAA, Alzheimer's disease (AD), and control (CS) participants, recruited from the Biomarkers
and Outcomes in CAA (BOCAA) study, and a Specialist Cognitive Disorders Service …

Background To evaluate the diagnostic accuracy of cerebrospinal fluid (CSF) biomarkers in
patients with probable cerebral amyloid angiopathy (CAA) according to the modified Boston
criteria in a retrospective multicentric cohort. Methods Beta-amyloid 1-40 (Aβ40), beta-
amyloid 1-42 (Aβ42), total tau (t-tau), and phosphorylated tau 181 (p-tau181) were
measured in 31 patients with probable CAA, 28 patients with Alzheimer's disease (AD), and
30 controls. Receiver-operating characteristics (ROC) analyses were performed for the …